Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gómez Serrano, María ^a   Camafeita, Emilio ^b   García Santos, Eva ^a   López, Juan A ^b   Rubio, Miguel A ^c   Sánchez Pernaute, Andrés ^c   Torres, Antonio ^c   Vázquez, Jesús ^b   Peral, Belén ^a,d  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

ADIPOSE TISSUE; ADULT; AGE; CLUSTER ANALYSIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEOMICS; SEXUAL CHARACTERISTICS; SYSTEMS BIOLOGY;

ADIPOSE TISSUE; ADULT; AGE FACTORS; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROTEOME; PROTEOMICS; SEX CHARACTERISTICS; SYSTEMS BIOLOGY;

EID: 84971350917     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25756     Document Type: Article

References (72)

1. James, W. P. The epidemiology of obesity: the size of the problem. J. Intern. Med. 263, 336-352, doi: 10.1111/j.1365-2796.2008.01922.x (2008).
2. Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556, doi: 10.1210/jc.2004-0395 (2004).
3. Wronska, A. & Kmiec, Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol. (Oxf.) 205, 194-208, doi: 10.1111/j.1748-1716.2012.02409.x (2012).
4. Graner, M. et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J. Clin. Endocrinol. Metab. 98, 1189-1197, doi: 10.1210/jc.2012-3190 (2013).
5. Neeland, I. J. et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308, 1150-1159, doi: 10.1001/2012.jama.11132 (2012).
6. American Diabetes, A. Standards of medical care in diabetes-2014. Diabetes Care 37, S14-80, doi: 10.2337/dc14-S014 (2014).
7. Stefan, N., Haring, H. U., Hu, F. B. & Schulze, M. B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1, 152-162, doi: 10.1016/S2213-8587(13)70062-7 (2013).
8. Perez-Perez, R. et al. Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue. J. Proteomics 75, 783-795, doi: 10.1016/j.jprot.2011.09.016 (2012).
9. Toubal, A., Treuter, E., Clement, K. & Venteclef, N. Genomic and epigenomic regulation of adipose tissue inflammation in obesity. Trends Endocrinol. Metab. 24, 625-634, doi: 10.1016/j.tem.2013.09.006 (2013).
10. Benabdelkamel, H. et al. Mature adipocyte proteome reveals differentially altered protein abundances between lean, overweight and morbidly obese human subjects. Mol. Cell. Endocrinol. 401, 142-154, doi: 10.1016/j.mce.2014.11.021 (2015).
11. Alfadda, A. A. et al. Proteomic analysis of mature adipocytes from obese patients in relation to aging. Exp. Gerontol. 48, 1196-1203, doi: 10.1016/j.exger.2013.07.008 (2013).
12. Mardinoglu, A. et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9, 649, doi: 10.1038/msb.2013.5 (2013).
13. Peral, B., Camafeita, E., Fernandez-Real, J. M. & Lopez, J. A. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev. Proteomics 6, 353-361, doi: 10.1586/epr.09.53 (2009).
14. Kim, E. Y. et al. Recent advances in proteomic studies of adipose tissues and adipocytes. Int. J. Mol. Sci. 16, 4581-4599, doi: 10.3390/ ijms16034581 (2015).
15. Altelaar, A. F., Munoz, J. & Heck, A. J. Next-generation proteomics: towards an integrative view of proteome dynamics. Nat. Rev. Genet. 14, 35-48, doi: 10.1038/nrg3356 (2013).
16. Luo, R. & Zhao, H. Protein quantitation using iTRAQ: Review on the sources of variations and analysis of nonrandom missingness. Stat. Interface 5, 99-107, doi: 10.4310/SII.2012.v5.n1.a9 (2012).
17. Navarro, P. et al. General statistical framework for quantitative proteomics by stable isotope labeling. J. Proteome Res. 13, 1234-1247, doi: 10.1021/pr4006958 (2014).
18. Martin-Alonso, M. et al. Deficiency of MMP17/MT4-MMP proteolytic activity predisposes to aortic aneurysm in mice. Circ. Res. 117, e13-26, doi: 10.1161/CIRCRESAHA.117.305108 (2015).
19. Quiros, P. M. et al. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep. 8, 542-556, doi: 10.1016/j.celrep.2014.06.018 (2014).
20. Strippoli, R. et al. Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis. EMBO Mol. Med. 7, 102-123, doi: 10.15252/emmm.201404127 (2015).
21. Barzilai, N., Huffman, D. M., Muzumdar, R. H. & Bartke, A. The critical role of metabolic pathways in aging. Diabetes 61, 1315-1322, doi: 10.2337/db11-1300 (2012).
22. Krotkiewski, M., Bjorntorp, P., Sjostrom, L. & Smith, U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72, 1150-1162, doi: 10.1172/JCI111040 (1983).
23. Goldberg, D. E. Genetic Algorithms in Search, Optimization and Machine Learning. (Addison-Wesley Longman Publishing Co., Inc., 1989).
24. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57, doi: 10.1038/nprot.2008.211 (2009).
25. Kim, S. J. et al. A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus. Mol. Cell. Proteomics 13, 811-822, doi: 10.1074/mcp.M113.035501 (2014).
26. Coma M., Aloy P., Pujol A., Gomis X., Oliva B., Lleo A. & Mas J. M., inventors; Anaxomics Biotech, assignee. Combination therapies for treating neurological disorders. United States Patent US 20,130,116,215. 2009 May 13.
27. Badiola, N. et al. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS One 8, e58837, doi: 10.1371/ journal.pone.0058837 (2013).
28. Pujol, A., Mosca, R., Farres, J. & Aloy, P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol. Sci. 31, 115-123, doi: 10.1016/j.tips.2009.11.006 (2010).
29. Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752-1761, doi: 10.1172/JCI21625 (2004).
30. Vernochet, C. et al. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 16, 765-776, doi: 10.1016/j.cmet.2012.10.016 (2012).
31. Gonzalez-Freire, M. et al. Reconsidering the Role of Mitochondria in Aging. J. Gerontol. A. Biol. Sci. Med. Sci. 70, 1334-1342, doi: 10.1093/gerona/glv070 (2015).
32. Fraga, M. F. & Esteller, M. Epigenetics and aging: the targets and the marks. Trends Genet. 23, 413-418, doi: 10.1016/j.tig.2007.05.008 (2007).
33. Larson, K. et al. Heterochromatin formation promotes longevity and represses ribosomal RNA synthesis. PLoS Genet. 8, e1002473, doi: 10.1371/journal.pgen.1002473 (2012).
34. Pasarica, M. et al. Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 94, 5155-5162, doi: 10.1210/jc.2009-0947 (2009).
35. Sun, K., Kusminski, C. M. & Scherer, P. E. Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101, doi: 10.1172/ JCI45887 (2011).
36. Simpson, E. R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86, 225-230, doi: 10.1016/S0960-0760(03)00360-1 (2003).
37. Patti, M. E. & Corvera, S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr. Rev. 31, 364-395, doi: 10.1210/ er.2009-0027 (2010).
38. Kusminski, C. M. & Scherer, P. E. Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol. Metab. 23, 435-443, doi: 10.1016/j.tem.2012.06.004 (2012).
39. Green, D. R., Galluzzi, L. & Kroemer, G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109-1112, doi: 10.1126/science.1201940 (2011).
40. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217, doi: 10.1016/j. cell.2013.05.039 (2013).
41. Russell, S. J. & Kahn, C. R. Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 8, 681-691, doi: 10.1038/nrm2234 (2007).
42. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950, doi: 10.2337/diabetes.51.10.2944 (2002).
43. Fu, S. et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473, 528-531, doi: 10.1038/nature09968 (2011).
44. Ortega, F. J. et al. Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes. J. Mol. Med. (Berl.) 91, 523-534, doi: 10.1007/s00109-012-0979-8 (2013).
45. Morino, K. et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587-3593, doi: 10.1172/JCI25151 (2005).
46. Demerath, E. W. et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) 15, 2984-2993, doi: 10.1038/oby.2007.356 (2007).
47. Camhi, S. M. et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 19, 402-408, doi: 10.1038/oby.2010.248 (2011).
48. Kanaley, J. A. et al. Abdominal fat distribution in pre-and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 50, 976-982, doi: 10.1053/meta.2001.24931 (2001).
49. White, U. A. & Tchoukalova, Y. D. Sex dimorphism and depot differences in adipose tissue function. Biochim. Biophys. Acta 1842, 377-392, doi: 10.1016/j.bbadis.2013.05.006 (2014).
50. Polderman, K. H., Gooren, L. J., Asscheman, H., Bakker, A. & Heine, R. J. Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab. 79, 265-271, doi: 10.1210/jcem.79.1.8027240 (1994).
51. Nandi, A., Chen, Z., Patel, R. & Poretsky, L. Polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 43, 123-147, doi: 10.1016/j.ecl.2013.10.003 (2014).
52. Wake, D. J. et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin. Endocrinol. (Oxf.) 66, 440-446, doi: 10.1111/j.1365-2265.2007.02755.x (2007).
53. Berndt, J. et al. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50, 1472-1480, doi: 10.1007/s00125-007-0689-x (2007).
54. Strissel, K. J. et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56, 2910-2918, doi: 10.2337/ db07-0767 (2007).
55. McGill, J. B. et al. Effect of gender on treatment outcomes in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 102, 167-174, doi: 10.1016/j.diabres.2013.10.001 (2013).
56. Chiu, C. J. & Wray, L. A. Gender differences in functional limitations in adults living with type 2 diabetes: biobehavioral and psychosocial mediators. Ann. Behav. Med. 41, 71-82, doi: 10.1007/s12160-010-9226-0 (2011).
57. Sato, H. et al. Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc. Res. 67, 714-722, doi: 10.1016/j.cardiores.2005.04.017 (2005).
58. Holzer, R. G. et al. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 147, 173-184, doi: 10.1016/j.cell.2011.08.034 (2011).
59. Migliaccio, E. et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 16, 706-716, doi: 10.1093/emboj/16.4.706 (1997).
60. Ranieri, S. C., Fusco, S. & Pani, G. p66(ShcA): linking mammalian longevity with obesity-induced insulin resistance. Vitam. Horm. 91, 219-241, doi: 10.1016/B978-0-12-407766-9.00009-2 (2013).
61. Tomilov, A. A. et al. The Shc locus regulates insulin signaling and adiposity in mammals. Aging Cell 10, 55-65, doi: 10.1111/j.1474-9726.2010.00641.x (2011).
62. Hacker, H., Tseng, P. H. & Karin, M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11, 457-468, doi: 10.1038/nri2998 (2011).
63. Chen, Z. et al. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am. J. Physiol. Endocrinol. Metab. 308, E460-469, doi: 10.1152/ajpendo.00470.2014 (2015).
64. Ezanno, H. et al. JNK3 is required for the cytoprotective effect of exendin 4. J. Diabetes Res. 2014, 814854, doi: 10.1155/2014/814854 (2014).
65. Clement, K. & Langin, D. Regulation of inflammation-related genes in human adipose tissue. J. Intern. Med. 262, 422-430, doi: 10.1111/j.1365-2796.2007.01851.x (2007).
66. Zhang, Q. et al. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J. Exp. Med. 210, 191-203, doi: 10.1084/jem.20111843 (2013).
67. Schiller, H. B. et al. Time-and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair. Mol. Syst. Biol. 11, 819, doi: 10.15252/msb.20156123 (2015).
68. Norhammar, A. & Schenck-Gustafsson, K. Type 2 diabetes and cardiovascular disease in women. Diabetologia 56, 1-9, doi: 10.1007/ s00125-012-2694-y (2013).
69. Jorge, I. et al. The human HDL proteome displays high inter-individual variability and is altered dynamically in response to angioplasty-induced atheroma plaque rupture. J. Proteomics 106, 61-73, doi: 10.1016/j.jprot.2014.04.010 (2014).
70. Galarraga, M. et al. Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. J. Lipid. Res. 53, 2791-2796, doi: 10.1194/jlr.D023788 (2012).
71. Russell, R. B. & Aloy, P. Targeting and tinkering with interaction networks. Nat. Chem. Biol. 4, 666-673, doi: 10.1038/nchembio.119 (2008).
72. Hulsen, T., de Vlieg, J. & Alkema, W. BioVenn -a web application for the comparison and visualization of biological lists using areaproportional Venn diagrams. BMC Genomics 9, 488, doi: 10.1186/1471-2164-9-488 (2008).